Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)

China flag China · Delayed Price · Currency is CNY
3.520
-0.030 (-0.85%)
Jun 2, 2026, 3:00 PM CST
Market Cap2.29B -49.5%
Revenue (ttm)173.47M -33.9%
Net Income-316.00M
EPS-0.47
Shares Out 651.90M
PE Ration/a
Forward PEn/a
Dividend0.08 (2.20%)
Ex-Dividend DateJul 15, 2025
Volume11,498,430
Open3.580
Previous Close3.550
Day's Range3.510 - 3.640
52-Week Range3.150 - 7.940
Beta0.24
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHA:603718

Shanghai Hile Bio-Technology Co., Ltd. develops, manufactures, and sells in vitro diagnostic reagents and oral tissue repair and regeneration materials in China. It operates through two segments: In Vitro Diagnostic Reagents and Oral Tissue Repair and Regeneration Materials. The In Vitro Diagnostic Reagents segment offers biochemical diagnostic reagents, immuno-latex reagents, immune turbidimetry reagents, latex enhanced immune turbidimetry reagents, enzyme-linked immunosorbent products, and related diagnostic kits, including matrix metalloprot... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 340
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603718
Full Company Profile

Financial Performance

Financial Statements